Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000597333 | SCV000703859 | pathogenic | not provided | 2016-12-06 | criteria provided, single submitter | clinical testing | |
Undiagnosed Diseases Network, |
RCV000735223 | SCV000863431 | likely pathogenic | Peroxisome biogenesis disorder 4B | 2018-09-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001384063 | SCV001583440 | pathogenic | Peroxisome biogenesis disorder | 2023-03-17 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp91*) in the PEX6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX6 are known to be pathogenic (PMID: 8670792, 19877282, 21031596). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PEX6-related conditions. ClinVar contains an entry for this variant (Variation ID: 498713). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003471954 | SCV004201570 | likely pathogenic | Heimler syndrome 2 | 2023-05-08 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000735223 | SCV000797119 | likely pathogenic | Peroxisome biogenesis disorder 4B | 2018-01-12 | no assertion criteria provided | clinical testing |